Lilly to invest $1 billion+ in new contract manufacturing in India
Investment to expand manufacturing and global medicine supply capacity
Investment to expand manufacturing and global medicine supply capacity
Commercial production is expected to begin soon
Jubilant HollisterStier is a subsidiary of Jubilant Pharma Holding
The USFDA has issued 15 observations pursuant to the completion of audit. JHSGP will submit an action plan on the observations
The US FDA in its communication mentioned it may withhold approval of any pending applications or supplements in which this facility is listed.
The move comes as the global biotech and biopharma CDMO market continues to surge, fueled by rising demand
The enhancements will improve environmental sustainability, strengthen material governance, and boost utility reliability
The company’s total income jumped 31% year-on-year to Rs 125.5 crore
The Chennai facility will manufacture high-quality medical tubing for neurovascular and cardiovascular applications, including balloon catheters and other minimally invasive devices
Subscribe To Our Newsletter & Stay Updated